RecruitingNCT07059962

Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)

Sensor-based Congestion Alert for Events in Peritoneal Dialysis (SCALE-PD)


Sponsor

Bodyport Inc.

Enrollment

125 participants

Start Date

Sep 9, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.


Eligibility

Min Age: 21 Years

Inclusion Criteria5

  • Age 21 years or older
  • Able to speak and read English, or able to speak and read Spanish and has a caregiver or family member who speaks English and can provide assistance
  • Able to stand on two bare feet unassisted
  • Receiving automated peritoneal dialysis for the treatment of ESKD
  • Followed on the Vantive Sharesource Remote Patient Management Platform

Exclusion Criteria6

  • Undergoing or plan to undergo hemodialysis in the next 12 months
  • Have a life expectancy of less than 12 months
  • Are pregnant or plan to become pregnant during the next 12 months
  • Weigh greater than 375 lbs
  • Planned kidney transplant within the next 12 months
  • Have an implanted neurostimulator system

Interventions

DEVICEBodyport Cardiac Scale

The Bodyport Cardiac Scale captures several physiological signals, which are used to derive multiple biomarkers that reflect a user's hemodynamic and fluid status.


Locations(4)

Desert Cities Dialysis

Victorville, California, United States

Southeastern Clinical Research Institute

Augusta, Georgia, United States

Northwestern University

Chicago, Illinois, United States

Seven Oaks General Hospital

Winnipeg, Manitoba, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07059962


Related Trials